BL PharmTech

BL PharmTech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BL PharmTech (065170.KQ) as of Oct 22, 2026 is 23.14 M KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -4.39 B KRW — a change of -100.53% (higher).

EBITDA

23.14 MKRW

YoY

-100.53%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BL PharmTech is 2025 23.14 M KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BL PharmTech was 2024 -4.39 B KRW. It decreases by -100.53% higher compared to the previous year.

The BL PharmTech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
2.07 B KRW
Jan 1, 2019
-23.60 B KRW
Jan 1, 2020
-15.30 B KRW
Jan 1, 2021
-3.11 B KRW
Jan 1, 2022
-7.87 B KRW
Jan 1, 2023
-8.21 B KRW
Jan 1, 2024
-4.39 B KRW
Jan 1, 2025
23.14 M KRW
The BL PharmTech EBITDA history
YEAREBITDAYoY
23.14 MKRW-100.53%
-4.39 BKRW-46.51%
-8.21 BKRW+4.27%
-7.87 BKRW+153.35%
-3.11 BKRW-79.70%
-15.30 BKRW-35.14%
-23.60 BKRW-1,238.83%
2.07 BKRW-28.19%
2.89 BKRW+47.02%
1.96 BKRW-301.83%
-972.42 MKRW-146.12%
2.11 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BL PharmTech Stock analysis

What does BL PharmTech do? BL PharmTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BL PharmTech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BL PharmTech is 23.14 M KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of BL PharmTech changed from -4.39 B KRW to 23.14 M KRW, representing a -100.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) BL PharmTech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s BL PharmTech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — BL PharmTech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BL PharmTech